Suven Pharmaceuticals Ltd.

NSE: SUVENPHAR | BSE: 543064

Expensive Performer

Download real time

1149.60 90.95 (8.59%)

92.24% Gain from 52W Low

663.2K NSE+BSE Volume

High volume+gain today

NSE 11 Apr, 2025 3:42 PM (IST)

29,264.8

Market Cap

High in industry

0.4

Beta 1Year

Very Low volatility

Analyst Buy

Goldman Sachs initiates a 'Buy' rating on Suven Pharma; sets a target price of Rs 1,350 See details

Suven Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Suven Pharmaceuticals Ltd. from all sources in a single place.

Load latest

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

22 Votes:

Buy 63.64%

Sell 13.64%

Hold 22.73%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >